Letters

I thank Michael Sokal for his warm praise of my book The Launching of Modern American Science, 1846-1876 (August 10, 1987, p. 25). I should like, however, to answer one mild criticism. Sokal feels that in alluding to certain scientific doings I should have described and discussed them in greater detail. In response I quote from my opening chapter: “Measured against what Europeans were doing in those years, lAmerican scientific] output was modest. The emphasis of this book will be on the

Written byRobert Bruce
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

I thank Michael Sokal for his warm praise of my book The Launching of Modern American Science, 1846-1876 (August 10, 1987, p. 25). I should like, however, to answer one mild criticism.

Sokal feels that in alluding to certain scientific doings I should have described and discussed them in greater detail. In response I quote from my opening chapter: “Measured against what Europeans were doing in those years, lAmerican scientific] output was modest. The emphasis of this book will be on the process more than the product, on the internal sociology, economics, and politics of science and on its interaction with the larger society. In these lies the real significance of the period.” Expatiating on the unremarkable and tangential would only have bloated the book and thinned its audience. Perhaps, however, I should have made it plainer to the reader that in almost all such cases, including those specifically cited ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies